Early failure of a pancreatic allograft due to complete thrombosis has an incidence of
approximately 10% and is the main cause of comorbidity in pancreas transplantation …

Pancreas graft failure rates remain substantial. The PDRI can be used at the time of organ
offering, to predict one‐year graft survival. This study aimed to validate the PDRI for a UK …

Background Risk indices such as the pancreas donor risk index (PDRI) and pre-
procurement pancreas allocation suitability score (P-PASS) are utilised in solid pancreas …

(1) Background: Simultaneous pancreas–kidney transplantation (SPKT) is a standard
therapeutic option for patients with diabetes mellitus type I and kidney failure. Early …

Background Pre-procurement pancreas suitability score (P-PASS) and pancreas donor risk
(PDRI) index are scoring systems believed to predict suitability of pancreatic grafts. Most …

Background: Pancreas transplantation (PTX) remains the most effective treatment to prevent
long-term complications and provide consistent euglycemia in patients with endocrine …

Background Donor obesity, defined as donor body mass index (D-BMI) of 30 kg/m 2 or
greater, has been associated with increased risk of technical failure and poor pancreas …

In cases after pancreas transplantation (PTx), the pancreas graft might be lost for various
reasons, including a pancreatoduodenal graft-related complication or patient death with a …

Simultaneous pancreas‐kidney transplantation (SPKT) is the best treatment for selected
individuals with type 1 diabetes mellitus and end‐stage renal disease. Despite advances in …

Background Simultaneous pancreas-kidney transplantation (SPKT) is the treatment of
choice for type 1 diabetes patients with end-stage renal disease. Donor characteristics are …